Chungcheongbuk-do Province Hosts 2022 CHUNGBUK BEST PRODUCT PROMOTION to Develop the Indonesian Market for Promising Export Companies in the Province

From August 26th to 28th, 30 Korean companies exhibit and sell their excellent products in Jakarta, Indonesia CHEONGJU, South Korea & JAKARTA, Indonesia–(BUSINESS WIRE)–#2022ChungbukBestProductPromotion–Chungcheongbuk-do has started to secure export channels for promising exporters in North Chungcheong Province to the Indonesian market. 2022 CHUNGBUK BEST PRODUCT PROMOTION will be held by Chungcheongbuk-do and Chungbuk Business Agency … [Read more…]

AdvanCell Closes A$18M Series B Funding Led by Morningside

Series B financing will accelerate growth and advance lead clinical program 212Pb-ADVC001 a best-in-class treatment for metastatic prostate cancer, expand manufacturing platform footprint and progress internal and partnership programs. SYDNEY–(BUSINESS WIRE)–#AdvanCell–AdvanCell, an Australian radiopharmaceutical company with a platform technology for a revolutionary cancer treatment called Targeted Alpha Therapy, announced today the closing of an A$18 … [Read more…]

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CCR8 Monoclonal Antibody CM369

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM369, an anti-CC chemokine receptor 8 (CCR8) monoclonal antibody, developed by a joint venture between the two companies called Tiannuojiancheng Pharma, has been approved by the China’s National Medical Products Administration (NMPA). CM369 is a … [Read more…]

GC Biopharma to Present New Data on Trends in Varicella Incidence Cases with Complications Among Korean Children at the 2022 ICPE

– Cases of Varicella infections have fallen by 92% in 10 years – Studies implies that the one-dose universal varicella vaccination program in Korea since 2005 has been successful in preventing chickenpox YONGIN, South Korea–(BUSINESS WIRE)–GC Biopharma (006280.KS) today announced that it will present new data demonstrating trends in the incidence of varicella cases with … [Read more…]

Babylon Appoints David Humphreys as Chief Financial Officer

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon Holdings Limited (NYSE:BBLN) (“Babylon” or the “Company”), one of the world’s fastest growing digital healthcare companies, announces that David Humphreys will be appointed as the Company’s new Chief Financial Officer. Mr. Humphreys has been at Babylon for nearly two years in the role of Finance Director, with overall responsibility for … [Read more…]

Anebulo Pharmaceuticals to Host Inaugural R&D Day in New York City on Monday, September 26

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), will host its inaugural R&D Day on Monday, September 26, 2022, from approximately 10:00 a.m. to 12:30 p.m. (ET) in Midtown, New York City. Anebulo’s … [Read more…]

Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health

Transaction Expands Labcorp’s Footprint with New Jersey’s leading academic health system BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets. RWJBarnabas Health is New Jersey’s largest academic health system. “The communities, physicians and health systems … [Read more…]

Mana Capital Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination

DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR) (the “Company” or “Mana Capital”) today announced that its Board of Directors has approved an extension of the period of time available to the Company to consummate its initial business combination by one month from August 26, 2022 to September 26, 2022 (the “Extension”), … [Read more…]

4imprint Grants Help More Than 600 Organizations Make Greater Impacts

4imprint® one by one® program assists nonprofits OSHKOSH, Wis.–(BUSINESS WIRE)–#4imprint–More than 600 organizations in the United States and Canada received 4imprint one by one® grants during the second quarter of 2022. From showing volunteers appreciation to serving the public, the $500 in-kind 4imprint grants of nonprofit promotional items are helping these organizations live out their … [Read more…]

Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results

–Record Annual Revenue and Growth Rate– — Fourth Quarter Revenue Increased 19% Year-Over-Year; Full Year Revenue Increased 16.5% — — Leveraging Strategic Investments to Accelerate Growth — NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 … [Read more…]